Direxion Daily S&P Biotech Bear 3X Shares LABD
6.85 USD -0.25 (-3.45%)
Nov 4, 2026, 9:58 AM EST
6.65 Day range 6.88
5.81 52-week range 33.24
- YTD
- -67.47%
- 1 year
- -78.41%
- Market cap
- 16.18M
- YTD return
- -67.47%
- 1-year return
- -78.41%
- Volume
- 7.12M
- Avg volume
- 21.28M
- Open
- 6.70
- Previous close
- 7.10
- Day's range
- 6.65 – 6.88
- 52-week range
- 5.81 – 33.24
1m -0.20 (-2.75%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 6.01
- 200-day average
- 6.90
About Direxion Daily S&P Biotech Bear 3X Shares
The fund, under normal circumstances, invests at least 80% of the fund’s net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the GICS. The fund is non-diversified.
News
EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks - These Are The Leveraged ETFs At Play When Trade War Worries Strike
Heaps Of Healthy Health Care ETFs 
Which Leveraged ETFs Will Be Hot This Week? 
This Little Nugget Of An ETF Is Delivering Astounding Returns - A New Bearish Biotech ETF And A Lazarus Act For A Couple Leveraged Funds
- Leveraged ETF Rebalancing: It's Not As Bad As It Seems
Wild Ride For Leveraged Biotech ETFs Continues - They're Heeere: Leveraged Cybersecurity ETFs
Even With Recent Declines, Investors Still Love Biotech ETFs
Your note
Sign in to keep a note on LABD — it syncs with the Stock Master app.